Aldeyra Therapeutics Inc (ALDX)
4.26
-0.14
(-3.29%)
USD |
NASDAQ |
Nov 14, 16:00
4.26
0.00 (0.00%)
After-Hours: 18:21
Aldeyra Therapeutics Enterprise Value: 156.66M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 156.66M |
| November 12, 2024 | 177.46M |
| November 11, 2024 | 221.14M |
| November 08, 2024 | 222.92M |
| November 07, 2024 | 212.22M |
| November 06, 2024 | 215.79M |
| November 05, 2024 | 208.06M |
| November 04, 2024 | 202.71M |
| November 01, 2024 | 213.41M |
| October 31, 2024 | 207.47M |
| October 30, 2024 | 212.22M |
| October 29, 2024 | 216.98M |
| October 28, 2024 | 228.86M |
| October 25, 2024 | 211.33M |
| October 24, 2024 | 214.30M |
| October 23, 2024 | 221.73M |
| October 22, 2024 | 245.50M |
| October 21, 2024 | 223.51M |
| October 18, 2024 | 233.61M |
| October 17, 2024 | 224.70M |
| October 16, 2024 | 225.29M |
| October 15, 2024 | 213.41M |
| October 14, 2024 | 218.16M |
| October 11, 2024 | 214.00M |
| October 10, 2024 | 211.03M |
| Date | Value |
|---|---|
| October 09, 2024 | 205.09M |
| October 08, 2024 | 206.87M |
| October 07, 2024 | 208.66M |
| October 04, 2024 | 212.22M |
| October 03, 2024 | 205.69M |
| October 02, 2024 | 209.85M |
| October 01, 2024 | 209.25M |
| September 30, 2024 | 215.19M |
| September 27, 2024 | 221.73M |
| September 26, 2024 | 214.00M |
| September 25, 2024 | 215.79M |
| September 24, 2024 | 230.64M |
| September 23, 2024 | 226.48M |
| September 20, 2024 | 244.90M |
| September 19, 2024 | 253.82M |
| September 18, 2024 | 243.72M |
| September 17, 2024 | 238.37M |
| September 16, 2024 | 246.09M |
| September 13, 2024 | 253.22M |
| September 12, 2024 | 262.73M |
| September 11, 2024 | 262.73M |
| September 10, 2024 | 247.28M |
| September 09, 2024 | 246.09M |
| September 06, 2024 | 259.17M |
| September 05, 2024 | 270.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-59.61M
Minimum
May 12 2022
624.27M
Maximum
Jun 08 2021
196.65M
Average
188.48M
Median
Nov 11 2020
Enterprise Value Benchmarks
| AbbVie Inc | 364.87B |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.85M |
| Total Expenses (Quarterly) | 18.01M |
| EPS Diluted (Quarterly) | -0.28 |
| Earnings Yield | -15.02% |